Media stories about Advanced Accelerator Application (NASDAQ:AAAP) have been trending somewhat positive this week, Accern reports. The research group identifies positive and negative news coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Advanced Accelerator Application earned a daily sentiment score of 0.06 on Accern’s scale. Accern also assigned media coverage about the company an impact score of 45.5569192055268 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.
Here are some of the news headlines that may have effected Accern Sentiment’s analysis:
- BRIEF-Advanced Accelerator Applications Announces Commencement Of Novartis Tender Offer (markets.businessinsider.com)
- Free Research Report as IDEXX Laboratories’ Revenue Grew 9.7% and EPS Surged 27.4% (finance.yahoo.com)
- Advanced Accelerator Applications Board Recommends $3.9 Bln Offer By Novartis (nasdaq.com)
- Analysts Anticipate Advanced Accelerator Application SA (AAAP) Will Post Quarterly Sales of $49.82 Million (americanbankingnews.com)
Several brokerages have weighed in on AAAP. J P Morgan Chase & Co downgraded Advanced Accelerator Application from an “overweight” rating to a “neutral” rating and set a $82.00 target price on the stock. in a research note on Monday, November 20th. Zacks Investment Research downgraded Advanced Accelerator Application from a “buy” rating to a “hold” rating in a research note on Wednesday, November 22nd. JMP Securities downgraded Advanced Accelerator Application from an “outperform” rating to a “market perform” rating in a research note on Monday, October 30th. Finally, Jefferies Group reiterated a “buy” rating and issued a $60.00 target price (up from $50.00) on shares of Advanced Accelerator Application in a research note on Friday, September 1st. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the company. Advanced Accelerator Application has an average rating of “Buy” and a consensus price target of $69.80.
TRADEMARK VIOLATION NOTICE: This piece was originally published by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are accessing this piece on another publication, it was illegally stolen and republished in violation of U.S. & international copyright & trademark legislation. The correct version of this piece can be viewed at https://www.chaffeybreeze.com/2017/12/08/somewhat-favorable-media-coverage-somewhat-unlikely-to-impact-advanced-accelerator-application-aaap-share-price.html.
About Advanced Accelerator Application
Advanced Accelerator Applications SA is a radiopharmaceutical company. The Company develops, produces and commercializes molecular nuclear medicine (MNM), diagnostic and therapeutic products. MNM uses trace amounts of radioactive compounds to create functional images of organs and lesions and to treat diseases, such as cancer.
Receive News & Ratings for Advanced Accelerator Application SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Accelerator Application SA and related companies with MarketBeat.com's FREE daily email newsletter.